• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种预测导管内乳头状黏液性肿瘤患者恶性程度的模型。

A model for predicting degree of malignancy in patients with intraductal papillary mucinous neoplasm.

作者信息

He Xiangyi, Fan Rong, Sun Jing, Ren Yanhao, Zhao Xuesong, Rui Weiwei, Yuan Yaozong, Zou Duowu

机构信息

Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

School of Mathematical Sciences, Fudan University, Shanghai, China.

出版信息

Front Oncol. 2023 Jan 24;13:1087852. doi: 10.3389/fonc.2023.1087852. eCollection 2023.

DOI:10.3389/fonc.2023.1087852
PMID:36761937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9902908/
Abstract

BACKGROUND/OBJECTIVES: There is no predictive model available to address early stage malignant intraductal papillary mucinous neoplasm (IPMN) including high grade dysplasia (HGD) and pT1a (invasive component≤0.5 cm). The aim of this study was to establish an objective and sufficient model to predict the degree of malignancy in patients with IPMN, which can be easily applied in daily practice and adopted for any type of lesion.

METHODS

A retrospective cohort study of 309 patients who underwent surgical resection for IPMN was performed. Members of the cohort were randomly allocated to the training or testing set. A detection tree model and random forest model were used for a 3-class classification to distinguish low grade dysplasia (LGD), HGD/pT1a IPMN, and invasive intraductal papillary mucinous cancer (I-IPMC) beyond pT1a.

RESULTS

Of the 309 patients, 54 (17.4%) had early stage malignancy (19 HGD, 35 pT1a), 49 (15.9%) had I-IPMC beyond pT1a, and 206 (66.7%) had LGD IPMN. We proposed a 3-class classification model using a random forest algorithm, and the model had an accuracy of 99.5% with the training set, and displayed an accuracy of 96.0% with the testing set. We used SHAP for interpretation of the model and showed the top five factors (mural nodule size, main pancreatic duct diameter, CA19-9 levels, lesion edge and common bile duct dilation) were most likely to influence the 3-class classification results in terms of interpretation of the random forest model.

CONCLUSIONS

This predictive model will help assess an individual's risk for different stages of IPMN malignancy and may help identify patients with IPMN who require surgery.

摘要

背景/目的:目前尚无预测模型可用于评估早期恶性导管内乳头状黏液性肿瘤(IPMN),包括高级别异型增生(HGD)和pT1a(浸润成分≤0.5 cm)。本研究的目的是建立一个客观且充分的模型,以预测IPMN患者的恶性程度,该模型可轻松应用于日常实践,并适用于任何类型的病变。

方法

对309例行IPMN手术切除的患者进行回顾性队列研究。队列成员被随机分配到训练集或测试集。使用检测树模型和随机森林模型进行三类分类,以区分低级别异型增生(LGD)、HGD/pT1a IPMN和pT1a以上的浸润性导管内乳头状黏液癌(I-IPMC)。

结果

在309例患者中,54例(17.4%)有早期恶性病变(19例HGD,35例pT1a),49例(15.9%)有pT1a以上的I-IPMC,206例(66.7%)有LGD IPMN。我们使用随机森林算法提出了一个三类分类模型,该模型在训练集上的准确率为99.5%,在测试集上的准确率为96.0%。我们使用SHAP对模型进行解释,并表明前五个因素(壁结节大小、主胰管直径、CA19-9水平、病变边缘和胆总管扩张)在随机森林模型的解释方面最有可能影响三类分类结果。

结论

该预测模型将有助于评估个体患不同阶段IPMN恶性肿瘤的风险,并可能有助于识别需要手术的IPMN患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e549/9902908/ff78d5af138d/fonc-13-1087852-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e549/9902908/170386cf3768/fonc-13-1087852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e549/9902908/0f4085652886/fonc-13-1087852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e549/9902908/cddcbc3f79aa/fonc-13-1087852-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e549/9902908/366c07a58654/fonc-13-1087852-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e549/9902908/ff78d5af138d/fonc-13-1087852-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e549/9902908/170386cf3768/fonc-13-1087852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e549/9902908/0f4085652886/fonc-13-1087852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e549/9902908/cddcbc3f79aa/fonc-13-1087852-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e549/9902908/366c07a58654/fonc-13-1087852-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e549/9902908/ff78d5af138d/fonc-13-1087852-g005.jpg

相似文献

1
A model for predicting degree of malignancy in patients with intraductal papillary mucinous neoplasm.一种预测导管内乳头状黏液性肿瘤患者恶性程度的模型。
Front Oncol. 2023 Jan 24;13:1087852. doi: 10.3389/fonc.2023.1087852. eCollection 2023.
2
MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.MUC2 表达与混合型胰管内乳头状黏液性肿瘤中高级别异型增生和浸润性癌的发生率。
Pancreatology. 2013 Nov-Dec;13(6):583-8. doi: 10.1016/j.pan.2013.08.007. Epub 2013 Aug 30.
3
[Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].[基于不同指南中的手术指征预测胰腺导管内乳头状黏液性肿瘤伴高级别异型增生或浸润性癌的诊断效能]
Zhonghua Wai Ke Za Zhi. 2021 May 1;59(5):359-365. doi: 10.3760/cma.j.cn112139-20200507-00365.
4
Branch duct intraductal papillary mucinous neoplasm of the pancreas: single-center experience with 324 patients who underwent surgical resection.胰腺分支导管内乳头状黏液性肿瘤:324例接受手术切除患者的单中心经验
Korean J Hepatobiliary Pancreat Surg. 2015 Aug;19(3):113-20. doi: 10.14701/kjhbps.2015.19.3.113. Epub 2015 Aug 28.
5
Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies.基于长期随访研究的胰腺导管内乳头状黏液性肿瘤术后复发危险因素:随访策略建议
J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):757-65. doi: 10.1002/jhbp.280. Epub 2015 Aug 3.
6
Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.浸润性混合型导管内乳头状黏液性肿瘤:与浸润性主胰管导管内乳头状黏液性肿瘤相比预后更佳。
Surgery. 2015 Oct;158(4):937-44; discussion 944-5. doi: 10.1016/j.surg.2015.06.003. Epub 2015 Jul 11.
7
Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.血清癌胚抗原和糖类抗原19-9在预测胰腺导管内乳头状黏液性肿瘤恶性程度中的临床意义
J Hepatobiliary Pancreat Sci. 2015 Sep;22(9):699-707. doi: 10.1002/jhbp.275. Epub 2015 Jul 14.
8
Neutrophil to Lymphocyte Ratio is a Predictive Factor of Malignant Potential for Intraductal Papillary Mucinous Neoplasms of the pancreas.中性粒细胞与淋巴细胞比值是胰腺导管内乳头状黏液性肿瘤恶性潜能的预测因子。
Biomark Insights. 2019 Jun 4;14:1177271919851505. doi: 10.1177/1177271919851505. eCollection 2019.
9
Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.影像学标准对导管内乳头状黏液性肿瘤(良、恶性)的诊治的影响。
Eur Radiol. 2015 May;25(5):1329-38. doi: 10.1007/s00330-014-3520-3. Epub 2014 Nov 30.
10
Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.胰腺侵袭性和非侵袭性导管内乳头状黏液性肿瘤的术前评估:123例临床、影像学及病理分析
Pancreas. 2009 Jan;38(1):8-16. doi: 10.1097/MPA.0b013e318181b90d.

引用本文的文献

1
Risk Factor and Prediction Model for Malignant Transformation in Pancreatic Intraductal Papillary Mucinous Neoplasm.胰腺导管内乳头状黏液性肿瘤恶性转化的危险因素及预测模型
Cancer Med. 2025 Sep;14(17):e71182. doi: 10.1002/cam4.71182.

本文引用的文献

1
Nomogram to predict malignancy in branch duct type intraductal papillary mucinous neoplasms.列线图预测分支状导管型乳腺导管内乳头状黏液性肿瘤的恶性程度。
Medicine (Baltimore). 2022 Sep 23;101(38):e30627. doi: 10.1097/MD.0000000000030627.
2
Predictors of adverse events after endoscopic ultrasound-guided through-the-needle biopsy of pancreatic cysts: a recursive partitioning analysis.内镜超声引导下经皮穿刺胰腺囊肿活检后不良事件的预测因素:递归分区分析。
Endoscopy. 2022 Dec;54(12):1158-1168. doi: 10.1055/a-1831-5385. Epub 2022 Apr 21.
3
Contrast-enhanced EUS for the characterization of mural nodules within pancreatic cystic neoplasms: systematic review and meta-analysis.
超声内镜增强造影对胰腺囊性肿瘤壁结节特征的评估:系统评价和荟萃分析。
Gastrointest Endosc. 2021 Nov;94(5):881-889.e5. doi: 10.1016/j.gie.2021.06.028. Epub 2021 Jul 1.
4
Differentiating benign from malignant pancreatic cysts on computed tomography.在计算机断层扫描上鉴别胰腺良性囊肿与恶性囊肿
Eur J Radiol Open. 2020 Nov 1;7:100278. doi: 10.1016/j.ejro.2020.100278. eCollection 2020.
5
The 2019 WHO classification of tumours of the digestive system.2019年世界卫生组织消化系统肿瘤分类。
Histopathology. 2020 Jan;76(2):182-188. doi: 10.1111/his.13975. Epub 2019 Nov 13.
6
New Model for Predicting Malignancy in Patients With Intraductal Papillary Mucinous Neoplasm.新模型预测导管内乳头状黏液性肿瘤患者的恶性肿瘤。
Ann Surg. 2020 Jul;272(1):155-162. doi: 10.1097/SLA.0000000000003108.
7
European evidence-based guidelines on pancreatic cystic neoplasms.欧洲胰腺囊性肿瘤循证临床实践指南。
Gut. 2018 May;67(5):789-804. doi: 10.1136/gutjnl-2018-316027. Epub 2018 Mar 24.
8
Fukuoka-Negative Branch-Duct IPMNs: When to Worry? A Study from the French Surgical Association (AFC).福冈阴性分支胰胆管内乳头状黏液瘤:何时需要担忧?来自法国外科协会(AFC)的研究。
Ann Surg Oncol. 2018 Apr;25(4):1017-1025. doi: 10.1245/s10434-017-6318-0. Epub 2018 Feb 1.
9
Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas.国际共识修订版福冈胰腺导管内乳头状黏液瘤管理指南。
Pancreatology. 2017 Sep-Oct;17(5):738-753. doi: 10.1016/j.pan.2017.07.007. Epub 2017 Jul 13.
10
Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas.2012 年国际共识指南预测胰腺分支胰管内乳头状黏液性肿瘤恶性程度的准确性。
United European Gastroenterol J. 2016 Aug;4(4):580-6. doi: 10.1177/2050640615623370. Epub 2016 Jan 6.